Tweet
Economic Times
<img alt="" height="1" width="1" />
Novartis in Regenerex Stem Cell Deal to Ease Kidney Transplants
Bloomberg
Novartis AG (NOVN) entered a collaboration with Regenerex LLC, gaining access to stem cell technology that may help kidney transplant patients avoid taking anti-rejection medicine for life. Regenerex, a startup biology company based in Louisville, ...
Novartis, Regenerex Ink Licensing, Research Collaboration - Quick FactsRTT News
Novartis signs deal to boost cell therapy portfolioEconomic Times
NOVARTIS AG : Novartis announces an exclusive global licensing and research ...4-traders (press release)
all 5 news articles »
More...